Top Feature

Jul 15, 2016
Pharmaceutical Executive
Pharm Exec sits down with Habib Dable, a 22-year veteran of Bayer, to discuss his first few months at the helm of the company’s US pharma operations.
Jul 07, 2016
Patients are buried in content, so it is a must to grab a share of the narrow bandwidths that they possess, writes Casey McDonald
Jul 05, 2016
The UK's Brexit vote has unleashed turbulence in Europe — not least on its pharma sector. Reflector reports.
Jul 01, 2016
Leela Barham looks at the implications for the UK industry in the aftermath of last week's vote for Brexit.
Jun 14, 2016
Pharmaceutical Executive
A new prognosis tool for the treatment of MS shows how an accessible visualization of disease state can serve as the threshold for fresh clinical insight.
Jun 13, 2016
Pharmaceutical Executive
Do recent trends in the pharma and biotech M&A and equity markets signal a temporary lull — or a permanent drop? Peter Young reports.
Jun 03, 2016
California is in the process of potentially establishing a new, disruptive healthcare policy that is proving to be very concerning to the American Rx industry, writes Tom Norton.
May 20, 2016
Pharmaceutical Executive
Pharm Exec’s 10th annual Brand of the Year has raced into the lead position in the treatment-shifting immuno-oncology space.
May 06, 2016
Pharmaceutical Executive
European pharma is bracing itself for EFPIA’s June deadline requiring the disclosure of transfer-of-value transactions make to HCPs.
May 05, 2016
Pharmaceutical Executive
A “how to” primer for life sciences companies on applying end-to-end evidence strategies in demonstrating product value.
native1_300x100
lorem ipsum